References
- Sadler EJ. von Willebrand factor: two sides of a coin. J Thromb Haemost. 2005;3:1702–9.
- Ketch TR, Turner SJ, Sacrinty MT, Lingle KC, Applegate RJ, Kutcher MA, et al.. ABO blood types: influence on infarct size, procedural characteristics and prognosis. Thromb Res. 2008;123:200–5.
- Sanchez-Luceros A, Meschengieser SS, Marchese C, Votta R, Casais P, Woods AI, et al.. Factor VIII and von Willebrand factor changes during normal pregnancy and puerperium. Blood Coagul Fibrinolysis. 2003;14:647–51.
- Sanchez-Luceros A, Farias CE, Amaral MM, Kempfer AC, Votta R, Marchese C, et al.. von Willebrand factor-cleaving protease (ADAMTS13) activity in normal non-pregnant women, pregnant and post-delivery women. Thromb Haemost. 2004;92:1320–6.
- Woods AI, Blanco AN, Chuit R, Meschengieser SS, Kempfer AC, Farías CE, et al.. Major haemorrhage related to surgery in patients with type1 and possible type1 von Willebrand disease. Thromb Haemost. 2008;100:797–802.
- Vischer UM. von Willebrand factor, endothelial dysfunction and cardiovascular disease. J Thromb Haemost. 2006;4:1186–93.
- Campos M, Sun W, Yu F, Barbalic M, Tang W, Chambless LE, et al.. Genetic determinants of plasma von Willebrand factor antigen level: a target gene SNP and haplotype analysis of ARIC cohort. Blood. 2011;117:5224–30.
- Roldán V, Marín F, Muiña B, Torregrosa JM, Hernández-Romero D, Valdés M, et al.. Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients. J Am Coll Cardiol. 2011;57:2496–504.
- Bongers TN, de Maat MPM, van Goor MLPJ, Bhagwanbali V, van Vliet HHDM, Garcia GomezEB, et al.. High von Willebrand factors levels increase the risk of first ischemic stroke. Stroke. 2006;37:2672–7.
- Montalescot G, Collet JP, Lison L. Effects of various anticoagulant treatments on von Willebrand factor release in unstable angina. J Am Coll Cardiol. 2000;36:110–4.